A Lancet trial found that adults who continued tirzepatide after major weight loss maintained more of their weight loss than those switched to placebo.
GLP-1 Medications and Heart Protection: What the Evidence Shows: cardiovascular outcome trial evidence, who benefits most, and how this drug class fits into.
Retatrutide: A New Horizon in Diabetes and Obesity Management: evidence-based guidance reviewed against current NICE and ADA recommendations. Practical.
Tirzepatide (Mounjaro): A Complete Guide: how it works, who it’s used for, common side effects, and current NICE NG28 guidance. Evidence-based guide from.
Managing GLP-1 Side Effects: A Practical Guide: practical strategies for managing common side effects, when to call your team, and how to stay on track.
What to Expect in Your First Month on Semaglutide: how it works, who it’s used for, common side effects, and current NICE NG28 guidance. Evidence-based guide.
Ozempic vs Wegovy vs Mounjaro: Complete Comparison: how it works, who it’s used for, common side effects, and current NICE NG28 guidance. Evidence-based.
